Terafab Tests Whether CHIPS Act Can Overcome Taiwan’s Structural Advantages
Intel's partnership with Musk's $25B fab project converges geopolitical decoupling, industrial policy, and semiconductor equipment disruption—but cost and execution gaps remain wide.
Elon Musk’s Terafab project, now partnered with Intel as its foundry, represents the most ambitious test yet of whether US industrial subsidies can overcome the structural cost advantages that have made Taiwan the dominant force in advanced semiconductor manufacturing. The initiative targets 2-nanometer process technology with an initial capacity of 100,000 wafer starts per month, scaling to 1 million starts monthly to produce up to 200 billion custom AI and memory chips annually, according to project specifications.
The capital requirements alone expose the challenge. Initial estimates from Leeds Insights place the project at $20-25 billion, but Morgan Stanley calculates meaningful capacity requires $35-45 billion, while a The Next Web report on Bernstein Research pegs the true cost of reaching one terawatt of annual compute at approximately $5 trillion. Even accepting the lower figures, the economics remain challenged: a new fab in the US costs 30% more to build and operate over ten years than one in Taiwan, South Korea, or Singapore, and 37-50% more than one in China, according to Semiconductor Industry Association data.
Intel’s Foundry Gambit
Intel’s April 7 entry as primary foundry partner sent its shares up 4% to $52.91, but the partnership highlights Intel Foundry’s precarious position as much as it validates Terafab’s viability. Intel Foundry generated just $307 million in external customer revenue in 2025, making Terafab’s potential contract orders of magnitude larger than the division’s current commercial base. “Our ability to design, fabricate, and package ultra-high-performance chips at scale will help accelerate Terafab’s aim to produce 1 TW/year of compute to power future advances in AI and robotics,” Intel stated in a corporate post.
“This is exactly what the CHIPS Act was designed to incentivize—major U.S. technology companies building critical semiconductor capacity on American soil. The Intel-Terafab partnership is the most significant domestic foundry commitment since TSMC announced its Arizona expansion.”
— Patrick Moorhead, CEO of Moor Insights & Strategy
The partnership leverages CHIPS Act provisions including $39 billion in subsidies for domestic chip manufacturing and 25% investment tax credits for equipment costs. But subsidies address only part of the structural disadvantage. US fabs take 38 months to build versus 20 months in Taiwan, with construction costs roughly double Taiwan’s. Speed and capital efficiency matter in an industry where lithography equipment depreciates rapidly and process node leadership shifts every 18-24 months.
The ASML Bottleneck
Even with funding and foundry capacity secured, Terafab faces a binding constraint: extreme ultraviolet lithography machines. ASML holds a monopoly on EUV systems required for nodes below 7nm, and its delivery schedule dictates how fast advanced AI compute capacity can scale globally. The company’s latest Twinscan EXE:5200 systems carry price tags exceeding €350 million each, and ASML raised its 2026 net sales guidance to €36-40 billion from €34-39 billion, citing accelerating AI infrastructure demand, per its Q1 2026 earnings report.
Taiwan’s TSMC manufactures over 60% of the world’s Semiconductors and 92% of advanced chips at 7nm and below, creating a strategic vulnerability the US has sought to address through export controls and domestic capacity buildout. Since October 2022, the US has coordinated with the Netherlands and Japan to restrict China’s access to advanced lithography and process technology, effectively bifurcating the semiconductor supply chain into competing geopolitical blocs.
“The semiconductor industry’s growth outlook continues to solidify, driven by ongoing AI-related infrastructure investments. Demand for chips is outpacing supply,” ASML CEO Christophe Fouquet stated in the earnings call. The company recognised revenue for a growing number of EXE:5200 systems in Q1, but total production remains limited by complex Supply Chains and export controls that restrict sales to China. Terafab will compete with TSMC, Samsung, and other advanced fabs for ASML’s limited annual output, with no guarantee of priority allocation despite geopolitical alignment.
Semiconductor Equipment Market Implications
Terafab’s equipment procurement represents potential disruption to the $132.66 billion semiconductor manufacturing equipment market assessed for 2026 by Research Nester. Early outreach to Applied Materials, Tokyo Electron, and Lam Research signals serious capital deployment intent. Lam Research reported $5.3 billion in revenue for its most recent quarter, up 28% year-over-year, reflecting broad industry capacity expansion.
- Terafab’s 100,000-1M wafer starts monthly target would require EUV tool allocations competitive with TSMC’s existing capacity expansion plans
- US fab construction timelines (38 months) create a 2029-2030 earliest production scenario, assuming no permitting or equipment delivery delays
- Intel Foundry’s $307M external revenue base makes Terafab orders critical to the division’s survival as a credible third-party foundry
- CHIPS Act subsidies cover ~15-20% of the 30-50% US cost premium, leaving significant economic gap versus Asian competitors
The project’s scale—eventual capacity of 1 million wafer starts monthly—would represent roughly 40% of TSMC’s current global advanced node capacity if fully realised. But that capacity took TSMC three decades and hundreds of billions in cumulative investment to build, with process expertise and supply chain relationships that cannot be replicated through capital alone.
What to Watch
Terafab’s progress will be measured in equipment orders, not announcements. Watch for confirmed ASML EXE:5200 allocations and delivery timelines—without priority access to EUV systems, the project cannot hit 2nm production targets regardless of funding. Intel’s ability to execute on advanced process nodes will become visible through its own product roadmap in late 2026 and 2027; delays there directly impact Terafab’s foundry viability. CHIPS Act funding disbursement remains tied to construction milestones and domestic content requirements, creating potential friction if global supply chains prove necessary for advanced equipment procurement.
The US-Netherlands-Japan export control coalition’s stability matters as much as domestic capacity buildout. Any fracture in that alliance could restore China’s access to advanced lithography, reducing the strategic premium on US-based production. TSMC’s Arizona fab ramp provides a parallel indicator of whether advanced semiconductor manufacturing can achieve competitive economics on US soil—so far, that facility has faced repeated delays and cost overruns.
Terafab represents Industrial Policy made concrete: either CHIPS Act subsidies and geopolitical imperative prove sufficient to overcome structural disadvantages, or Taiwan’s decades of accumulated advantage in cost, speed, and execution remain insurmountable. Intel’s foundry partnership and Musk’s capital raise capability provide the best-case scenario for US semiconductor sovereignty. The market will know within 18 months whether that scenario is realistic or aspirational.